An Open-label, Multi-center, Long-term Study to Evaluate the Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis
Phase of Trial: Phase III
Latest Information Update: 04 Sep 2015
Price : $35 *
At a glance
- Drugs Pefcalcitol (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors Maruho
- 01 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 04 Nov 2014 Planned End Date changed from 1 Sep 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov record.